
Mankind Pharma Ltd
Market Capital : 97,727.47 Cr.
P/E Ratio : 47.87
P/B Ratio : 9.83
Book Value Per Share : 239.04
EPS : 47.68
Dividend Yield : 0.00 %
Revenue Growth : 23.90 %
Profit Growth : 49.23 %
Market Capital : 97,727.47 Cr.
P/E Ratio : 47.87
P/B Ratio : 9.83
Book Value Per Share : 239.04
EPS : 47.68
Dividend Yield : 0.00 %
Revenue Growth : 23.90 %
Profit Growth : 49.23 %
Strengths
Weaknesses
COMPANY NAME | CURRENT PRICE | PE RATIO | REVENUE GROWTH | PROFIT GROWTH |
---|---|---|---|---|
₹1,819 |
38.14 |
10.46% |
13.01% |
|
₹6,161 |
79.13 |
25.01% |
-12.25% |
|
₹1,511 |
24.46 |
7.10% |
47.10% |
|
₹1,160 |
18.03 |
15.81% |
23.75% |
|
₹3,270 |
59.44 |
2.82% |
33.02% |
|
₹877 |
18.87 |
16.96% |
96.88% |
|
₹2,049 |
32.62 |
10.97% |
345.15% |
As per the National Stock Exchange, Mankind Pharma Ltd’s ticker symbol is "MANKIND".
The Mankind Pharma Ltd’s market capitalization is ₹ 97727.47 Cr.
As of now, the Mankind Pharma Ltd’s market capitalization is ₹97727.47 Cr, which puts it into the category of large-cap companies. This can indicate, the Mankind Pharma Ltd is stable and Established in the industry. If you finding a company to invest in that is less risky, has consistent growth and a stable dividend yield then this can be good to go.